3rd Annual UT Southwestern Neurotherapeutics Update (RP1710A)

Dallas, TX US
October 28, 2017

The Neurotherapeutics Update CME live activity will provide a review and update in key areas of clinical neurology. Emphasis will be placed on updates for diagnosis, management, and the most current treatment modalities that have practical applications for neurologists, other clinicians, and health care professionals.


Target Audience

This CME activity is designed for Physicians, Advance Practice Nurses, Physician Assistants, Registered Nurses, Physical Therapists, Allied Health Professionals, and other healthcare professionals that specialize in neuroscience and neurotherapeutics, who are interested in learning about the most current treatment modalities and best management practices, in order to improve patient care and health outcomes.


Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Assess most up-to-date diagnosis and management recommendations for treating patients with MS.
  • Discuss neuro-ophthalmology diagnostic approach and most up-to-date management recommendations in optic nerve and oculomotor disorders.
  • Evaluate the most current surgical options of treating epilepsy patients and the diagnostic studies involved in the process of identifying the appropriate patients.
  • Identify the major types of primary and secondary brain tumors, and broad treatment strategies  in the treatment of tumors.
  • Describe identification, diagnosis, and management of all treatable ataxias.
  • Recognize clinical presentations and management of non-Alzheimer’s dementias.
  • Apply clinical applications, safety, methodology, and prognosis of use of chemodenervation in dystonia.
  • Expalin different pharmacologic options, applications, safety, and efficacy in treating patients with neurovascular disorders.
  • Interpret the role of clinical exome sequencing in neurologic disease, including its benefits to patients, limitations, appropriate use, and billing
  • Assess current pharmacologic recommendations in peripheral neuropathy.
  • Review what is currently known about the possible association between ZIKV infection and the development of severe neurological disorders.
Course summary
Available credit: 
  • 7.00 AMA
  • 7.00 Attendance
  • 1.00 Ethics
Course opens: 
Course expires: 
Event starts: 
10/28/2017 - 7:00am CDT
Event ends: 
10/28/2017 - 4:30pm CDT
T. Boone Pickens Biomedical Building
6001 Forest Park
UT Southwestern Medical Center
Dallas, TX 75235
United States


Jaya Trivedi, MD , FAAN, FANA
Department of Neurology & Neurotherapeutics

Steven Vernino, MD, PhD 
Department of Neurology & Neurotherapeutics


Accreditation and Credit Designation Statements

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The University of Texas Southwestern Medical Center designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 


UT Southwestern University Hospitals is an approved provider of continuing nursing education by the Texas Nurses Association – Approver, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 6.16 contact hours.


To register:

  1. Create an account in EthosCE, online learning management system, by selecting the "create an account" link at the bottom of the page or "log-in" to your existing account.
  2. Return to this course page, select the designated fee and click on "add to cart" at the bottom of the page.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

Available Credit

  • 7.00 AMA
  • 7.00 Attendance
  • 1.00 Ethics


Please login or create an account to take this course.